Cabergoline | |
---|---|
Molecular structure via molpic | |
Conformer structure via 3Dmol.js | |
Molecular formula | C26H37N5O2[1] |
Molecular mass | 451.6 g/mol[1] |
Predicted LogP | 3.4[1] |
Melting point | 102-104 °C[1] |
Solubility | Insoluble[1] |
Chirality | absolute[2] |
Identifiers [] | |
---|---|
IUPAC name | (6aR,9R,10aR)-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)-7-prop-2-enyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide[1] |
SMILES | CCNC(=O)N(CCCN(C)C)C(=O)[C@@H]1C[C@H]2[C@@H](CC3=CNC4=CC=CC2=C34)N(C1)CC=C[1] |
InChI | InChI=1S/C26H37N5O2/c1-5-11-30-17-19(25(32)31(26(33)27-6-2)13-8-12-29(3)4)14-21-20-9-7-10-22-24(20)18(16-28-22)15-23(21)30/h5,7,9-10,16,19,21,23,28H,1,6,8,11-15,17H2,2-4H3,(H,27,33)/t19-,21-,23-/m1/s1[1] |
InChIKey | KORNTPPJEAJQIU-KJXAQDMKSA-N[1] |
Dosing | |
---|---|
Elimination half-life | 63–69 hours (estimated) |
Cabergoline
Cabergoline (also known as Cabergolina, Cabergolinum, Velactis, Caberlin, 1-((6-Allylergolin-8β-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea, 1-ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'β-carbonyl)urea, 1-[(6-allylergoline-8β-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea, (8R)-6-allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide, (8β)-N-[3-(dimethylamino)propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide or Ergoline-8-carboxamide, N-(3-(dimethylamino)propyl)-N-((ethylamino)carbonyl)-6-(2-propenyl)-, (8-β)-) is a substance of the lysergamide class.
Chemistry
Stereochemistry
Cabergoline is a absolute mixture
Legal status
- Australia: Cabergoline is a S4.[3]
- United States: Cabergoline is a prescription only.
See also
External links
- Cabergoline (Wikipedia)
- Cabergoline (Wikidata)
- Cabergoline (DrugBank)
- Cabergoline (PubChem)
- Cabergoline (ChEMBL)
- Cabergoline (ChEBI)
- Cabergoline (Common Chemistry)
- Cabergoline (HMDB)
- Cabergoline (KEGG)
- Cabergoline (UNII)
- Cabergoline (EPA DSSTox)
References
National Center for Biotechnology Information. PubChem Compound Summary for CID 54746, Cabergoline. Accessed June 17, 2025. https://pubchem.ncbi.nlm.nih.gov/compound/54746.
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Cabergoline. UNII: LL60K9J05T. Global Substance Registration System. Accessed June 17, 2025. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/LL60K9J05T
Carbelin (Nova Pharmaceuticals Australasia Pty Ltd). September 13, 2024. Accessed June 17, 2025. https://www.tga.gov.au/resources/prescription-medicines-registrations/carbelin-nova-pharmaceuticals-australasia-pty-ltd